世界の上皮腫治療市場は現在、2023年に約48億6,000万米ドルと評価されており、2024年から2032年の予測期間にわたって10.4％のCAGRで拡大すると予想されています。
上皮細胞に由来するがんの一種である上皮腫は、長時間の日光曝露、環境汚染物質、遺伝的素因、皮膚悪性腫瘍の発生率の増加などの要因により、世界中で診断が急増しています。基底細胞がん、扁平上皮がん、その他の上皮悪性腫瘍の有病率の増加により、高度な治療ソリューションの需要が高まっています。進行中の臨床研究により、製薬会社は患者の転帰を向上させ、治療関連の毒性を軽減するために、標的療法、免疫療法、生物学的製剤の開発を積極的に行っています。
免疫療法と標的薬物療法における継続的な革新により、上皮腫の治療パラダイムは大きく変わりました。免疫チェックポイント阻害薬とハリネズミ経路阻害薬は効果的な治療法として登場しており、従来の化学療法と比較して優れた効果を発揮します。さらに、個別化医療は、遺伝子プロファイリングに基づいて治療戦略を調整し、最適な治療反応を確保する上で重要な役割を果たしています。しかし、新規治療法の高コストと低所得地域でのアクセスの制限は、市場拡大に課題を引き起こす可能性があります。こうしたハードルにもかかわらず、世界の医療業界では、薬の有効性を高め、治療の経済的負担を軽減することを目的とした研究開発に多額の投資が行われています。
地理的には、強力な医療インフラ、高い意識レベル、腫瘍研究への広範な資金提供により、北アメリカが上皮腫治療市場を支配しています。アメリカは先進医療施設と新しいがん治療法の早期導入の恩恵を受け、市場をリードしています。ヨーロッパもこれに緊密に追従しており、革新的な医薬品や治療法の導入を支援する強力な規制枠組みが整備されています。一方、アジア太平洋地域は、がん罹患率の上昇、医療費の増加、最先端の治療法へのアクセスの拡大により、最も速い成長率を記録すると予想されています。ラテンアメリカ、中東、アフリカも潜在的な市場として浮上しており、政府はがん治療インフラの改善と手頃な価格を重視しています。
目次
Table of Contents
Chapter 1. Global Epithelioma Treatment Market Executive Summary
1.1. Global Epithelioma Treatment Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Type
1.3.2. By Drug Class
1.3.3. By Distribution Channel
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Epithelioma Treatment Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Epithelioma Treatment Market Dynamics
3.1. Market Drivers
3.1.1. Rising Incidence of Epithelioma and Skin Malignancies
3.1.2. Advancements in Targeted Therapies and Immunotherapies
3.1.3. Increased Investment in Oncology Research and Development
3.2. Market Challenges
3.2.1. High Cost of Novel Therapies
3.2.2. Limited Accessibility in Low-Income Regions
3.3. Market Opportunities
3.3.1. Expansion in Emerging Markets
3.3.2. Development of Personalized Medicine
3.3.3. Strategic Collaborations and Partnerships
Chapter 4. Global Epithelioma Treatment Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Epithelioma Treatment Market Size & Forecasts by Type 2022-2032
5.1. Segment Dashboard
5.2. Global Epithelioma Treatment Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
5.2.1. Basal Cell Carcinoma
5.2.2. Squamous Cell Carcinoma
5.2.3. Others
Chapter 6. Global Epithelioma Treatment Market Size & Forecasts by Drug Class 2022-2032
6.1. Segment Dashboard
6.2. Global Epithelioma Treatment Market: Drug Class Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
6.2.1. Hedgehog Pathway Inhibitors
6.2.2. Immune Checkpoint Inhibitors
Chapter 7. Global Epithelioma Treatment Market Size & Forecasts by Distribution Channel 2022-2032
7.1. Segment Dashboard
7.2. Global Epithelioma Treatment Market: Distribution Channel Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
7.2.1. Hospital Pharmacies
7.2.2. Retail Pharmacies
7.2.3. Online Pharmacies
Chapter 8. Global Epithelioma Treatment Market Size & Forecasts by Region 2022-2032
8.1. North America Epithelioma Treatment Market
8.1.1. U.S. Epithelioma Treatment Market
8.1.1.1. Basal Cell Carcinoma Breakdown Size & Forecasts, 2022-2032
8.1.1.2. Squamous Cell Carcinoma Breakdown Size & Forecasts, 2022-2032
8.1.1.3. Hedgehog Pathway Inhibitors Breakdown Size & Forecasts, 2022-2032
8.1.1.4. Immune Checkpoint Inhibitors Breakdown Size & Forecasts, 2022-2032
8.1.1.5. Hospital Pharmacies Breakdown Size & Forecasts, 2022-2032
8.1.1.6. Retail Pharmacies Breakdown Size & Forecasts, 2022-2032
8.1.1.7. Online Pharmacies Breakdown Size & Forecasts, 2022-2032
8.1.2. Canada Epithelioma Treatment Market
8.2. Europe Epithelioma Treatment Market
8.2.1. U.K. Epithelioma Treatment Market
8.2.2. Germany Epithelioma Treatment Market
8.2.3. France Epithelioma Treatment Market
8.2.4. Spain Epithelioma Treatment Market
8.2.5. Italy Epithelioma Treatment Market
8.2.6. Rest of Europe Epithelioma Treatment Market
8.3. Asia-Pacific Epithelioma Treatment Market
8.3.1. China Epithelioma Treatment Market
8.3.2. India Epithelioma Treatment Market
8.3.3. Japan Epithelioma Treatment Market
8.3.4. Australia Epithelioma Treatment Market
8.3.5. South Korea Epithelioma Treatment Market
8.3.6. Rest of Asia Pacific Epithelioma Treatment Market
8.4. Latin America Epithelioma Treatment Market
8.4.1. Brazil Epithelioma Treatment Market
8.4.2. Mexico Epithelioma Treatment Market
8.4.3. Rest of Latin America Epithelioma Treatment Market
8.5. Middle East & Africa Epithelioma Treatment Market
8.5.1. Saudi Arabia Epithelioma Treatment Market
8.5.2. South Africa Epithelioma Treatment Market
8.5.3. Rest of Middle East & Africa Epithelioma Treatment Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Pfizer Inc.
9.1.2. Merck & Co., Inc.
9.1.3. Novartis AG
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Pfizer Inc.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. AstraZeneca plc
9.3.3. GlaxoSmithKline plc
9.3.4. Sanofi S.A.
9.3.5. Eli Lilly and Company
9.3.6. Amgen Inc.
9.3.7. Regeneron Pharmaceuticals, Inc.
9.3.8. AbbVie Inc.
9.3.9. Takeda Pharmaceutical Company Limited
9.3.10. Bayer AG
9.3.11. Bristol-Myers Squibb Company
9.3.12. Johnson & Johnson
9.3.13. F. Hoffmann-La Roche Ltd
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
List of Tables
TABLE 1. Global Epithelioma Treatment Market, Report Scope
TABLE 2. Global Epithelioma Treatment Market Estimates & Forecasts by Region 2022-2032 (USD Million/Billion)
TABLE 3. Global Epithelioma Treatment Market Estimates & Forecasts by Type 2022-2032 (USD Million/Billion)
TABLE 4. Global Epithelioma Treatment Market Estimates & Forecasts by Drug Class 2022-2032 (USD Million/Billion)
TABLE 5. Global Epithelioma Treatment Market Estimates & Forecasts by Distribution Channel 2022-2032 (USD Million/Billion)
TABLE 6. Global Epithelioma Treatment Market by Segment, Estimates & Forecasts, 2022-2032 (USD Million/Billion)
TABLE 7. Global Epithelioma Treatment Market by Region, Estimates & Forecasts, 2022-2032 (USD Million/Billion)
TABLE 8. Global Epithelioma Treatment Market by Segment, Estimates & Forecasts, 2022-2032 (USD Million/Billion)
TABLE 9. Global Epithelioma Treatment Market by Region, Estimates & Forecasts, 2022-2032 (USD Million/Billion)
TABLE 10. Global Epithelioma Treatment Market by Segment, Estimates & Forecasts, 2022-2032 (USD Million/Billion)
TABLE 11. Global Epithelioma Treatment Market by Region, Estimates & Forecasts, 2022-2032 (USD Million/Billion)
TABLE 12. Global Epithelioma Treatment Market by Segment, Estimates & Forecasts, 2022-2032 (USD Million/Billion)
TABLE 13. Global Epithelioma Treatment Market by Region, Estimates & Forecasts, 2022-2032 (USD Million/Billion)
TABLE 14. Global Epithelioma Treatment Market by Segment, Estimates & Forecasts, 2022-2032 (USD Million/Billion)
TABLE 15. U.S. Epithelioma Treatment Market Estimates & Forecasts, 2022-2032 (USD Million/Billion)
TABLE 16. U.S. Epithelioma Treatment Market Estimates & Forecasts by Type 2022-2032 (USD Million/Billion)
TABLE 17. U.S. Epithelioma Treatment Market Estimates & Forecasts by Drug Class 2022-2032 (USD Million/Billion)
TABLE 18. Canada Epithelioma Treatment Market Estimates & Forecasts, 2022-2032 (USD Million/Billion)
TABLE 19. Canada Epithelioma Treatment Market Estimates & Forecasts by Type 2022-2032 (USD Million/Billion)
TABLE 20. Canada Epithelioma Treatment Market Estimates & Forecasts by Drug Class 2022-2032 (USD Million/Billion)
…..
This list is not complete; the final report contains more than 100 tables. The list may be updated in the final deliverable.
List of Figures
FIG 1. Global Epithelioma Treatment Market, Research Methodology
FIG 2. Global Epithelioma Treatment Market, Market Estimation Techniques
FIG 3. Global Market Size Estimates & Forecast Methods
FIG 4. Global Epithelioma Treatment Market, Key Trends 2023
FIG 5. Global Epithelioma Treatment Market, Growth Prospects 2022-2032
FIG 6. Global Epithelioma Treatment Market, Porter’s 5 Force Model
FIG 7. Global Epithelioma Treatment Market, PESTEL Analysis
FIG 8. Global Epithelioma Treatment Market, Value Chain Analysis
FIG 9. Global Epithelioma Treatment Market by Segment, 2022 & 2032 (USD Million/Billion)
FIG 10. Global Epithelioma Treatment Market by Segment, 2022 & 2032 (USD Million/Billion)
FIG 11. Global Epithelioma Treatment Market by Segment, 2022 & 2032 (USD Million/Billion)
FIG 12. Global Epithelioma Treatment Market by Segment, 2022 & 2032 (USD Million/Billion)
FIG 13. Global Epithelioma Treatment Market by Segment, 2022 & 2032 (USD Million/Billion)
FIG 14. Global Epithelioma Treatment Market, Regional Snapshot 2022 & 2032
FIG 15. North America Epithelioma Treatment Market 2022 & 2032 (USD Million/Billion)
FIG 16. Europe Epithelioma Treatment Market 2022 & 2032 (USD Million/Billion)
FIG 17. Asia Pacific Epithelioma Treatment Market 2022 & 2032 (USD Million/Billion)
FIG 18. Latin America Epithelioma Treatment Market 2022 & 2032 (USD Million/Billion)
FIG 19. Middle East & Africa Epithelioma Treatment Market 2022 & 2032 (USD Million/Billion)
FIG 20. Global Epithelioma Treatment Market, Company Market Share Analysis (2023)
…..
This list is not complete; the final report contains more than 50 figures. The list may be updated in the final deliverable.
